Verona Pharma plc (VRNA) Financials
VRNA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 356.7 million | 35.3 million |
2023-06-30 | 383.7 million | 38.9 million |
2023-03-31 | 400.4 million | 57.5 million |
2022-12-31 | 314.0 million | 35.1 million |
VRNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -15.5 million | 6.2 million |
2023-06-30 | -26.9 million | 6.4 million |
2023-03-31 | -7.2 million | 5.3 million |
2022-12-31 | -9.4 million | 5.5 million |
VRNA Net Income
No data available :(
VRNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 313.9 million | - | 483001 |
2023-06-30 | 341.8 million | - | 725911 |
2023-03-31 | 361.1 million | - | 885893 |
2022-12-31 | 275.7 million | - | 1.1 million |
VRNA Shares Outstanding
VRNA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 3.6 million | 16.3 million | - |
2023-06-30 | - | 3.1 million | 15.7 million | - |
2023-03-31 | - | 15.6 million | 11.9 million | - |
2022-12-31 | - | 8.3 million | 10.1 million | - |
VRNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | 554245 | 418709 |
VRNA
Price: $15.69
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -30.25
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 555000
Ebitda: -10.7 millionMarket Capitalization: 1.3 billion